147 related articles for article (PubMed ID: 31237889)
1. Do changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data.
Baecker A; Kim S; Risch HA; Nuckols TK; Wu BU; Hendifar AE; Pandol SJ; Pisegna JR; Jeon CY
PLoS One; 2019; 14(6):e0218580. PubMed ID: 31237889
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model in a Diverse and Integrated Healthcare Setting.
Chen W; Butler RK; Lustigova E; Chari ST; Wu BU
Dig Dis Sci; 2021 Jan; 66(1):78-87. PubMed ID: 32112260
[TBL] [Abstract][Full Text] [Related]
3. Prediction of pancreatic cancer risk in patients with new-onset diabetes using a machine learning approach based on routine biochemical parameters.
Cichosz SL; Jensen MH; Hejlesen O; Henriksen SD; Drewes AM; Olesen SS
Comput Methods Programs Biomed; 2024 Feb; 244():107965. PubMed ID: 38070389
[TBL] [Abstract][Full Text] [Related]
4. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma.
Yu S; Li Y; Liao Z; Wang Z; Wang Z; Li Y; Qian L; Zhao J; Zong H; Kang B; Zou WB; Chen K; He X; Meng Z; Chen Z; Huang S; Wang P
Gut; 2020 Mar; 69(3):540-550. PubMed ID: 31562239
[TBL] [Abstract][Full Text] [Related]
5. The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis.
Jeon CY; Pandol SJ; Wu B; Cook-Wiens G; Gottlieb RA; Merz CN; Goodman MT
PLoS One; 2015; 10(4):e0121783. PubMed ID: 25830309
[TBL] [Abstract][Full Text] [Related]
6. A pancreatic cancer risk prediction model (Prism) developed and validated on large-scale US clinical data.
Jia K; Kundrot S; Palchuk MB; Warnick J; Haapala K; Kaplan ID; Rinard M; Appelbaum L
EBioMedicine; 2023 Dec; 98():104888. PubMed ID: 38007948
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a pancreatic cancer risk model for the general population using electronic health records: An observational study.
Appelbaum L; Cambronero JP; Stevens JP; Horng S; Pollick K; Silva G; Haneuse S; Piatkowski G; Benhaga N; Duey S; Stevenson MA; Mamon H; Kaplan ID; Rinard MC
Eur J Cancer; 2021 Jan; 143():19-30. PubMed ID: 33278770
[TBL] [Abstract][Full Text] [Related]
8. Identifying symptoms associated with diagnosis of pancreatic exocrine and neuroendocrine neoplasms: a nested case-control study of the UK primary care population.
Liao W; Clift AK; Patone M; Coupland C; González-Izquierdo A; Pereira SP; Hippisley-Cox J
Br J Gen Pract; 2021 Nov; 71(712):e836-e845. PubMed ID: 34544691
[TBL] [Abstract][Full Text] [Related]
9. Glycemic Changes and Weight Loss Precede Pancreatic Ductal Adenocarcinoma by up to 3 Years in a Diverse Population.
Brewer MJ; Doucette JT; Bar-Mashiah A; Glickman JW; Kessel E; Aronson A; Lucas AL
Clin Gastroenterol Hepatol; 2022 May; 20(5):1105-1111.e2. PubMed ID: 34358720
[TBL] [Abstract][Full Text] [Related]
10. The association of new-onset diabetes with subsequent diagnosis of pancreatic cancer-novel use of a large administrative database.
White MJ; Sheka AC; LaRocca CJ; Irey RL; Ma S; Wirth KM; Benner A; Denbo JW; Jensen EH; Ankeny JS; Ikramuddin S; Tuttle TM; Hui JYC; Marmor S
J Public Health (Oxf); 2023 Jun; 45(2):e266-e274. PubMed ID: 36321614
[TBL] [Abstract][Full Text] [Related]
11. Epilepsy Among Elderly Medicare Beneficiaries: A Validated Approach to Identify Prevalent and Incident Epilepsy.
Moura LMVR; Smith JR; Blacker D; Vogeli C; Schwamm LH; Cole AJ; Hernandez-Diaz S; Hsu J
Med Care; 2019 Apr; 57(4):318-324. PubMed ID: 30762723
[TBL] [Abstract][Full Text] [Related]
12. Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.
Sah RP; Sharma A; Nagpal S; Patlolla SH; Sharma A; Kandlakunta H; Anani V; Angom RS; Kamboj AK; Ahmed N; Mohapatra S; Vivekanandhan S; Philbrick KA; Weston A; Takahashi N; Kirkland J; Javeed N; Matveyenko A; Levy MJ; Mukhopadhyay D; Chari ST
Gastroenterology; 2019 May; 156(6):1742-1752. PubMed ID: 30677401
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory cytokines and combined biomarker panels in pancreatic ductal adenocarcinoma: Enhancing diagnostic accuracy.
Kruger D; Yako YY; Devar J; Lahoud N; Smith M
PLoS One; 2019; 14(8):e0221169. PubMed ID: 31415645
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
[TBL] [Abstract][Full Text] [Related]
16. Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma.
Henriksen SD; Madsen PH; Larsen AC; Johansen MB; Drewes AM; Pedersen IS; Krarup H; Thorlacius-Ussing O
Clin Epigenetics; 2016; 8():117. PubMed ID: 27891190
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags.
Sogawa K; Takano S; Iida F; Satoh M; Tsuchida S; Kawashima Y; Yoshitomi H; Sanda A; Kodera Y; Takizawa H; Mikata R; Ohtsuka M; Shimizu H; Miyazaki M; Yokosuka O; Nomura F
Br J Cancer; 2016 Oct; 115(8):949-956. PubMed ID: 27657339
[TBL] [Abstract][Full Text] [Related]
18. The use of magnetic resonance elastography in differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A preliminary study.
Shi Y; Cang L; Zhang X; Cai X; Wang X; Ji R; Wang M; Hong Y
Eur J Radiol; 2018 Nov; 108():13-20. PubMed ID: 30396645
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.
Brand R; Borazanci E; Speare V; Dudley B; Karloski E; Peters MLB; Stobie L; Bahary N; Zeh H; Zureikat A; Hogg M; Lee K; Tsung A; Rhee J; Ohr J; Sun W; Lee J; Moser AJ; DeLeonardis K; Krejdovsky J; Dalton E; LaDuca H; Dolinsky J; Colvin A; Lim C; Black MH; Tung N
Cancer; 2018 Sep; 124(17):3520-3527. PubMed ID: 30067863
[TBL] [Abstract][Full Text] [Related]
20. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
